Eunju Song

Dr. Eunju Song

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2023 in Cells
Verified
Journal Article
Open access
PDF file
SKSo-mi Kang
So-mi Kang
SSSeungwoon Seo
Seungwoon Seo
ESEunju Song
Eunju Song
OKOkhee Kweon
Okhee Kweon
AJAh-Hyeon Jo
Ah-Hyeon Jo
BPBum-Joon Park
Bum-Joon Park
Hutchinson–Gilford Progeria Syndrome (HGPS) is an ultra-rare human premature aging disorder that precipitates death because of cardiac disease. Almost all cases of HGPS are caused by aberrant splicing of the LMNA gene that results in the production of a mutant Lamin A protein termed progerin. In our previous study, treatment with Progerinin has been shown to reduce progerin expression and improve aging phenotypes in vitro and in vivo HGPS models. In this record, cardiac parameters (stroke volume (SV), ejection fraction (EF), fractional shortening (FS), etc.) were acquired in LmnaWT/WT and LmnaG609G/WT mice fed with either a vehicle diet or a Progerinin diet by echocardiography (from 38 weeks to 50 weeks at various ages), and then the cardiac function was analyzed. We also acquired the tissue samples and blood serum of LmnaWT/WT and LmnaG609G/WT mice for pathological analysis at the end of echocardiography. From these data, we suggest that the administration of Progerinin in the HGPS model mouse can restore cardiac function and correct arterial abnormalities. These observations provide encouraging evidence for the efficacy of Progerinin for cardiac dysfunction in HGPS.

1 December 2025 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
MCMichael D. Clark
Michael D. Clark
YKYerin Kim
Yerin Kim
CRCesar A. Romero
Cesar A. Romero
DKDong Won Kang
Dong Won Kang
KBKyung In Baek
Kyung In Baek
HJHanjoong Jo
Hanjoong Jo